Windtree Therapeutics Sells Cardiovascular Drug Candidates to Seismic Pharmaceutical Holdings
I'm PortAI, I can summarize articles.
Windtree Therapeutics has agreed to sell its cardiovascular drug candidates to Seismic Pharmaceutical Holdings. Windtree will receive 20% of milestone payments, royalties, and global commercial net revenues from these assets. Additionally, Windtree is eligible for a $700,000 payment if Seismic secures at least $10 million in financing. The deal also transfers certain development payables from Windtree to Seismic, relieving Windtree of future funding obligations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments